CAY10746

CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively. CAY10746 can be employed in the study of diabetic retinopathy.

Product Specifications

CAS Number

2247240-76-0

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

457.48

Molecular Formula

C26H23N3O5

Notes

Research use only, not for human use.

Receptor

ROCK

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1583308-01 50 Tests

Anti-Human CD13/ANPEP Antibody (WM-15), APC

Ask

View Details

MBS1583308-02 100 Tests

Anti-Human CD13/ANPEP Antibody (WM-15), APC

Ask

View Details

MBS1583308-03 5x 100 Tests

Anti-Human CD13/ANPEP Antibody (WM-15), APC

Ask

View Details

588586 50 µg

NPAL3 (NIPA-like Domain Containing 3, DJ462O23.2, DKFZp686E22155)

Ask

View Details

48571021 500 ng

TSKU Protein Vector (Human) (pPM-C-HA)

Ask

View Details

GTR15248503 1 Vial

Lentiviral mouse Ccdc25 shRNA (UAS) - Lentiviral mouse Ccdc25 shRNA (UAS) plasmid

Ask

View Details